ABVX

#795
Abivax SA - American Depositary Shares
132.6 0 USD
+2.39%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
131.00
133.50
Faixa anual
5.69
148.83
Mudança diária
+2.39%
Mudança mensal
+22.22%
Mudança em 6 meses
+5.87%
Mudança anual
+2106.32%
Fechamento anterior
129.5 0
Open
131.7 8
Mínimo
131.0 0
High
133.5 0
Volume
920
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Notícias